Inventor · disambiguated record
Kimberly Vanover
Also filed as: VANOVER KIMBERLY · VANOVER KIMBERLY E
25 granted patents·18 pending applications·585 citations·filing 2004–2025
97Inventor score
Top patents by PatentIndex Score
43 records- 0198US12090155B2MethodsINTRA CELLULAR THERAPIES INC·Filed 2023·Granted Sep 17, 2024·13 cites·27 claims
- 0298US11958852B2Compounds and methodsINTRA CELLULAR THERAPIES INC·Filed 2021·Granted Apr 16, 2024·11 cites·16 claims
- 0398US11844757B2Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2020·Granted Dec 19, 2023·10 cites·14 claims
- 0498US11773095B2Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2022·Granted Oct 3, 2023·9 cites·21 claims
- 0598US11753419B24-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)-1-(4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)phenyl)butan-1-one for treating conditions of the central nervous system and cardiac disordersINTRA CELLULAR THERAPIES INC·Filed 2020·Granted Sep 12, 2023·6 cites·26 claims
- 0698US11427587B2Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2018·Granted Aug 30, 2022·31 cites·13 claims
- 0798US11124514B2Compositions and methodsINTRA CELLULAR THERAPIES INC·Filed 2019·Granted Sep 21, 2021·40 cites·14 claims
- 0898US11053245B2MethodsINTRA CELLULAR THERAPIES INC·Filed 2013·Granted Jul 6, 2021·40 cites·19 claims
- 0998US11026951B2Methods of treating bipolar disorderINTRA CELLULAR THERAPIES INC·Filed 2019·Granted Jun 8, 2021·38 cites·24 claims
- 1098US10960010B2Pharmaceutical compositions for sustained or delayed releaseINTRA CELLULAR THERAPIES INC·Filed 2019·Granted Mar 30, 2021·38 cites·24 claims
- 1198US10960009B2Methods of treating schizophrenia and depressionINTRA CELLULAR THERAPIES INC·Filed 2019·Granted Mar 30, 2021·39 cites·19 claims
- 1298US10799500B2Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2019·Granted Oct 13, 2020·28 cites·17 claims
- 1398US10322134B2MethodsINTRA CELLULAR THERAPIES INC·Filed 2018·Granted Jun 18, 2019·49 cites·20 claims
- 1498US10245260B2Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2017·Granted Apr 2, 2019·38 cites·15 claims
- 1598US9956227B2Method for the treatment of residual symptoms of schizophreniaINTRA CELLULAR THERAPIES INC·Filed 2014·Granted May 1, 2018·78 cites·25 claims
- 1698US9428506B2Substituted pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines for the treatment of nervous system disordersINTRA CELLULAR THERAPIES INC·Filed 2013·Granted Aug 30, 2016·82 cites·30 claims
- 1797US12122792B2Pharmaceutical compositions comprising 4-((6bR,10aS)-3-methyl2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin8(7H)-yl)-1-(4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)phenyl)butan-1-one for treating conditions of the central nervous system and cardiac disordersINTRA CELLULAR THERAPIES INC·Filed 2023·Granted Oct 22, 2024·3 cites·35 claims
- 1897US11376249B2Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2018·Granted Jul 5, 2022·29 cites·19 claims
- 1994US12173004B2Pharmaceutical compositions comprising heterocycle fused gamma carboline prodrugsINTRA CELLULAR THERAPIES INC·Filed 2023·Granted Dec 24, 2024·1 cites·24 claims
- 2090US2025360140A1Novel methodsINTRA CELLULAR THERAPIES INC·Filed 2025·Application pending·0 cites
- 2189US2025382310A1Organic compoundINTRA CELLULAR THERAPIES INC·Filed 2025·Application pending·0 cites
- 2288US12410195B2Pharmaceutical compositions comprising 4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)-1-(4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)phenyl)butan-1-one for treating conditions of the central nervous system and cardiac disordersINTRA CELLULAR THERAPIES INC·Filed 2024·Granted Sep 9, 2025·0 cites·24 claims
- 2388US2024024334A1Novel methodsINTRA CELLULAR THERAPIES INC·Filed 2023·Application pending·0 cites
- 2485US12440489B2Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2023·Granted Oct 14, 2025·0 cites·17 claims
- 2581US2024374586A1Novel methodsINTRA CELLULAR THERAPIES INC·Filed 2024·Application pending·0 cites
- 2678US12365650B2Deuterated organic compounds and uses thereofENGRAIL THERAPEUTICS INC·Filed 2024·Granted Jul 22, 2025·1 cites·26 claims
- 2777US2021322433A1Novel methodsINTRA CELLULAR THERAPIES INC·Filed 2021·Application pending·0 cites
- 2876US12325726B2Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2019·Granted Jun 10, 2025·1 cites·28 claims
- 2975US2025090536A1UsesINTRA CELLULAR THERAPIES INC·Filed 2024·Application pending·0 cites
- 3073US2020407362A1Novel methodsINTRA CELLULAR THERAPIES INC·Filed 2020·Application pending·0 cites
- 3173US2021002280A1Novel methodsINTRA CELLULAR THERAPIES INC·Filed 2020·Application pending·0 cites
- 3269US2022296591A1Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2022·Application pending·0 cites
- 3368US2025312340A1Methods of treating neuropathic painINTRA CELLULAR THERAPIES INC·Filed 2025·Application pending·0 cites
- 3465US2021000822A1Novel methodsINTRA CELLULAR THERAPIES INC·Filed 2020·Application pending·0 cites
- 3557US2022184072A1Methods of treating neuropathic painINTRA CELLULAR THERAPIES INC·Filed 2020·Application pending·0 cites
- 3656US12194042B2UsesINTRA CELLULAR THERAPIES INC·Filed 2019·Granted Jan 14, 2025·0 cites·18 claims
- 3755US12195463B2Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2019·Granted Jan 14, 2025·0 cites·14 claims
- 3854US2023355625A1Methods of treatmentINTRA CELLULAR THERAPIES INC·Filed 2020·Application pending·0 cites
- 3953US2021186962A1Methods of schizophrenia treatmentINTRA CELLULAR THERAPIES INC·Filed 2020·Application pending·0 cites
- 4049US2022088014A1Methods of treating addictionINTRA CELLULAR THERAPIES INC·Filed 2020·Application pending·0 cites
- 4146US2005136444A1Treating neuropathic pain with neuropeptide FF receptor 2 agonistsFiled 2004·Application pending·0 cites
- 4244US2005130961A1Muscarinic M1 receptor agonists for pain managementFiled 2004·Application pending·0 cites
- 4338US2025091990A1Deuterated organic compounds and uses thereofENGRAIL THERAPEUTICS INC·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kimberly Vanover files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →